Collegium Pharmaceutical, Inc.COLLNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
163.16%
↑ 368% above average
Average (39q)
34.85%
Historical baseline
Range
High:2200.00%
Low:-1667.16%
Volatility
11095.5%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 163.16% |
| Q2 2025 | 400.00% |
| Q1 2025 | -80.51% |
| Q4 2024 | 18.18% |
| Q3 2024 | -45.00% |
| Q2 2024 | -30.23% |
| Q1 2024 | -13.13% |
| Q4 2023 | 62.30% |
| Q3 2023 | 60.53% |
| Q2 2023 | 174.51% |
| Q1 2023 | -142.86% |
| Q4 2022 | -1667.16% |
| Q3 2022 | 108.93% |
| Q2 2022 | 61.54% |
| Q1 2022 | 46.58% |
| Q4 2021 | -417.39% |
| Q3 2021 | -88.83% |
| Q2 2021 | 357.78% |
| Q1 2021 | 125.00% |
| Q4 2020 | -39.39% |
| Q3 2020 | 43.48% |
| Q2 2020 | 2200.00% |
| Q1 2020 | 115.27% |
| Q4 2019 | 63.61% |
| Q3 2019 | -28.57% |
| Q2 2019 | 51.72% |
| Q1 2019 | -207.41% |
| Q4 2018 | 154.00% |
| Q3 2018 | -25.00% |
| Q2 2018 | 29.82% |
| Q1 2018 | -5.56% |
| Q4 2017 | -20.00% |
| Q3 2017 | 37.50% |
| Q2 2017 | 8.86% |
| Q1 2017 | 22.55% |
| Q4 2016 | 9.73% |
| Q3 2016 | -7.62% |
| Q2 2016 | -54.41% |
| Q1 2016 | -47.83% |
| Q4 2015 | 0.00% |